Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer

Although immunotherapy has emerged as an effective therapeutic strategy for various cancers including head and neck squamous cell carcinomas (HNSCCs), only a subset of patients can benefit from such therapy. Hence, it is pressing to discover predictive biomarkers for cancer immunotherapy response. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Haoyu, Li, Mengyuan, Jiang, Zehang, Liu, Zhixian, Wang, Xiaosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695281/
https://www.ncbi.nlm.nih.gov/pubmed/31428295
http://dx.doi.org/10.1016/j.csbj.2019.07.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695281/
https://www.ncbi.nlm.nih.gov/pubmed/31428295
http://dx.doi.org/10.1016/j.csbj.2019.07.009

Ejemplares similares